Annual FCF
-$37.34 M
+$6.27 M+14.38%
December 31, 2023
Summary
- As of March 6, 2025, ABEO annual free cash flow is -$37.34 million, with the most recent change of +$6.27 million (+14.38%) on December 31, 2023.
- During the last 3 years, ABEO annual FCF has fallen by -$985.00 thousand (-2.71%).
- ABEO annual FCF is now -5774.77% below its all-time high of $658.00 thousand, reached on December 31, 1995.
Performance
ABEO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$12.64 M
+$757.00 K+5.65%
September 30, 2024
Summary
- As of March 6, 2025, ABEO quarterly free cash flow is -$12.64 million, with the most recent change of +$757.00 thousand (+5.65%) on September 30, 2024.
- Over the past year, ABEO quarterly FCF has stayed the same.
- ABEO quarterly FCF is now -665.71% below its all-time high of $2.23 million, reached on December 31, 2006.
Performance
ABEO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$50.57 M
-$6.85 M-15.66%
September 30, 2024
Summary
- As of March 6, 2025, ABEO TTM free cash flow is -$50.57 million, with the most recent change of -$6.85 million (-15.66%) on September 30, 2024.
- Over the past year, ABEO TTM FCF has stayed the same.
- ABEO TTM FCF is now -23085.45% below its all-time high of $220.00 thousand, reached on March 31, 2014.
Performance
ABEO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ABEO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.4% | 0.0% | 0.0% |
| 3 y3 years | -2.7% | -17.7% | -33.2% |
| 5 y5 years | +36.3% | +34.1% | +27.1% |
ABEO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.5% | -118.3% | +62.3% | -35.4% | +27.6% |
| 5 y | 5-year | -2.7% | +46.5% | -669.2% | +62.3% | -39.1% | +27.6% |
| alltime | all time | -5774.8% | +46.5% | -665.7% | +62.3% | <-9999.0% | +39.0% |
Abeona Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.64 M(-5.7%) | -$50.57 M(+15.7%) |
| Jun 2024 | - | -$13.39 M(-12.2%) | -$43.72 M(+7.6%) |
| Mar 2024 | - | -$15.26 M(+64.6%) | -$40.64 M(+8.8%) |
| Dec 2023 | -$37.34 M(-14.4%) | -$9.27 M(+60.1%) | -$37.34 M(-11.3%) |
| Sep 2023 | - | -$5.79 M(-43.9%) | -$42.09 M(-2.3%) |
| Jun 2023 | - | -$10.32 M(-13.8%) | -$43.09 M(+3.1%) |
| Mar 2023 | - | -$11.96 M(-14.7%) | -$41.78 M(-4.2%) |
| Dec 2022 | -$43.61 M(-37.5%) | -$14.02 M(+106.3%) | -$43.61 M(-30.9%) |
| Sep 2022 | - | -$6.79 M(-24.6%) | -$63.10 M(-5.9%) |
| Jun 2022 | - | -$9.01 M(-34.6%) | -$67.04 M(-3.6%) |
| Mar 2022 | - | -$13.79 M(-58.8%) | -$69.58 M(-0.3%) |
| Dec 2021 | -$69.82 M(+92.0%) | -$33.51 M(+212.1%) | -$69.82 M(+83.9%) |
| Sep 2021 | - | -$10.74 M(-7.0%) | -$37.95 M(-0.6%) |
| Jun 2021 | - | -$11.55 M(-17.7%) | -$38.19 M(+4.1%) |
| Mar 2021 | - | -$14.03 M(+753.9%) | -$36.67 M(+0.9%) |
| Dec 2020 | -$36.35 M(-47.6%) | -$1.64 M(-85.0%) | -$36.35 M(-25.9%) |
| Sep 2020 | - | -$10.97 M(+9.4%) | -$49.08 M(-14.3%) |
| Jun 2020 | - | -$10.03 M(-26.9%) | -$57.30 M(-14.1%) |
| Mar 2020 | - | -$13.71 M(-4.6%) | -$66.73 M(-3.7%) |
| Dec 2019 | -$69.33 M(+18.3%) | -$14.37 M(-25.1%) | -$69.33 M(-16.3%) |
| Sep 2019 | - | -$19.19 M(-1.4%) | -$82.84 M(+11.4%) |
| Jun 2019 | - | -$19.47 M(+19.4%) | -$74.35 M(+10.4%) |
| Mar 2019 | - | -$16.30 M(-41.5%) | -$67.33 M(+14.9%) |
| Dec 2018 | -$58.60 M(+149.2%) | -$27.88 M(+160.6%) | -$58.60 M(+60.7%) |
| Sep 2018 | - | -$10.70 M(-14.0%) | -$36.47 M(+11.8%) |
| Jun 2018 | - | -$12.44 M(+64.1%) | -$32.62 M(+29.6%) |
| Mar 2018 | - | -$7.58 M(+31.9%) | -$25.17 M(+7.0%) |
| Dec 2017 | -$23.52 M(+73.8%) | -$5.75 M(-16.0%) | -$23.52 M(+11.0%) |
| Sep 2017 | - | -$6.84 M(+37.1%) | -$21.18 M(+14.6%) |
| Jun 2017 | - | -$4.99 M(-15.8%) | -$18.47 M(+10.5%) |
| Mar 2017 | - | -$5.93 M(+73.9%) | -$16.72 M(+23.6%) |
| Dec 2016 | -$13.53 M(+26.1%) | -$3.41 M(-17.5%) | -$13.53 M(+2.0%) |
| Sep 2016 | - | -$4.14 M(+27.6%) | -$13.27 M(+13.7%) |
| Jun 2016 | - | -$3.24 M(+18.2%) | -$11.67 M(+13.3%) |
| Mar 2016 | - | -$2.74 M(-12.8%) | -$10.30 M(-4.0%) |
| Dec 2015 | -$10.73 M(+566.1%) | -$3.14 M(+23.8%) | -$10.73 M(+23.5%) |
| Sep 2015 | - | -$2.54 M(+35.3%) | -$8.69 M(+38.1%) |
| Jun 2015 | - | -$1.88 M(-40.9%) | -$6.29 M(+35.0%) |
| Mar 2015 | - | -$3.17 M(+187.8%) | -$4.66 M(+189.1%) |
| Dec 2014 | -$1.61 M(>+9900.0%) | -$1.10 M(+687.1%) | -$1.61 M(+63.7%) |
| Sep 2014 | - | -$140.00 K(-42.6%) | -$984.00 K(-44.1%) |
| Jun 2014 | - | -$244.00 K(+95.2%) | -$1.76 M(-900.5%) |
| Mar 2014 | - | -$125.00 K(-73.7%) | $220.00 K(<-9900.0%) |
| Dec 2013 | -$1000.00(-100.0%) | -$475.00 K(-48.2%) | -$1000.00(-99.9%) |
| Sep 2013 | - | -$917.00 K(-152.8%) | -$1.14 M(+61.7%) |
| Jun 2013 | - | $1.74 M(-602.0%) | -$705.00 K(-78.1%) |
| Mar 2013 | - | -$346.00 K(-78.6%) | -$3.22 M(-18.9%) |
| Dec 2012 | -$3.97 M(-48.1%) | -$1.61 M(+234.9%) | -$3.97 M(-8.1%) |
| Sep 2012 | - | -$482.00 K(-38.0%) | -$4.32 M(-36.8%) |
| Jun 2012 | - | -$777.00 K(-29.0%) | -$6.83 M(-13.3%) |
| Mar 2012 | - | -$1.09 M(-44.2%) | -$7.88 M(+3.1%) |
| Dec 2011 | -$7.65 M | -$1.96 M(-34.5%) | -$7.65 M(+3.4%) |
| Sep 2011 | - | -$3.00 M(+64.0%) | -$7.40 M(+29.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | -$1.83 M(+112.8%) | -$5.72 M(+3.3%) |
| Mar 2011 | - | -$859.00 K(-49.9%) | -$5.54 M(-19.4%) |
| Dec 2010 | -$6.87 M(+205.2%) | -$1.72 M(+30.6%) | -$6.87 M(+10.1%) |
| Sep 2010 | - | -$1.31 M(-20.2%) | -$6.24 M(+34.8%) |
| Jun 2010 | - | -$1.65 M(-24.9%) | -$4.63 M(+16.6%) |
| Mar 2010 | - | -$2.19 M(+101.7%) | -$3.97 M(+76.3%) |
| Dec 2009 | -$2.25 M(-76.1%) | -$1.09 M(-465.7%) | -$2.25 M(-23.1%) |
| Sep 2009 | - | $297.00 K(-130.1%) | -$2.93 M(-61.1%) |
| Jun 2009 | - | -$987.00 K(+108.2%) | -$7.52 M(+6.7%) |
| Mar 2009 | - | -$474.00 K(-73.1%) | -$7.05 M(-25.2%) |
| Dec 2008 | -$9.42 M(+93.8%) | -$1.76 M(-59.0%) | -$9.42 M(+1.7%) |
| Sep 2008 | - | -$4.29 M(+732.4%) | -$9.26 M(+62.0%) |
| Jun 2008 | - | -$516.00 K(-81.9%) | -$5.72 M(-10.7%) |
| Mar 2008 | - | -$2.85 M(+77.9%) | -$6.40 M(+31.7%) |
| Dec 2007 | -$4.86 M(+147.9%) | -$1.60 M(+112.5%) | -$4.86 M(+373.3%) |
| Sep 2007 | - | -$753.00 K(-37.4%) | -$1.03 M(-10.5%) |
| Jun 2007 | - | -$1.20 M(-8.0%) | -$1.15 M(-40.2%) |
| Mar 2007 | - | -$1.31 M(-158.5%) | -$1.92 M(-2.1%) |
| Dec 2006 | -$1.96 M(-73.2%) | $2.23 M(-355.6%) | -$1.96 M(-71.5%) |
| Sep 2006 | - | -$874.00 K(-55.7%) | -$6.88 M(-5.7%) |
| Jun 2006 | - | -$1.97 M(+46.5%) | -$7.29 M(-1.0%) |
| Mar 2006 | - | -$1.35 M(-49.8%) | -$7.37 M(+0.5%) |
| Dec 2005 | -$7.33 M(-15.1%) | -$2.68 M(+107.7%) | -$7.33 M(+8.1%) |
| Sep 2005 | - | -$1.29 M(-36.9%) | -$6.78 M(-11.4%) |
| Jun 2005 | - | -$2.05 M(+56.1%) | -$7.66 M(-2.1%) |
| Mar 2005 | - | -$1.31 M(-38.5%) | -$7.82 M(-9.4%) |
| Dec 2004 | -$8.63 M(+33.0%) | -$2.13 M(-1.6%) | -$8.63 M(+2.8%) |
| Sep 2004 | - | -$2.17 M(-1.9%) | -$8.39 M(-7.2%) |
| Jun 2004 | - | -$2.21 M(+3.9%) | -$9.04 M(+35.6%) |
| Mar 2004 | - | -$2.13 M(+12.1%) | -$6.67 M(+2.8%) |
| Dec 2003 | -$6.49 M(-27.9%) | -$1.90 M(-32.7%) | -$6.49 M(0.0%) |
| Sep 2003 | - | -$2.81 M(-1816.5%) | -$6.49 M(-1.8%) |
| Jun 2003 | - | $164.00 K(-108.4%) | -$6.61 M(-25.0%) |
| Mar 2003 | - | -$1.94 M(+2.6%) | -$8.81 M(-2.1%) |
| Dec 2002 | -$9.00 M(+58.1%) | -$1.90 M(-35.4%) | -$9.00 M(+7.4%) |
| Sep 2002 | - | -$2.93 M(+43.8%) | -$8.38 M(+7.1%) |
| Jun 2002 | - | -$2.04 M(-4.4%) | -$7.82 M(+11.4%) |
| Mar 2002 | - | -$2.13 M(+67.3%) | -$7.02 M(+23.4%) |
| Dec 2001 | -$5.69 M(+29.3%) | -$1.27 M(-46.4%) | -$5.69 M(+3.1%) |
| Sep 2001 | - | -$2.38 M(+92.2%) | -$5.52 M(+23.1%) |
| Jun 2001 | - | -$1.24 M(+54.8%) | -$4.49 M(+0.1%) |
| Mar 2001 | - | -$800.00 K(-27.5%) | -$4.48 M(+1.7%) |
| Dec 2000 | -$4.40 M(+35.5%) | -$1.10 M(-17.8%) | -$4.40 M(-3.1%) |
| Sep 2000 | - | -$1.34 M(+8.9%) | -$4.54 M(+13.6%) |
| Jun 2000 | - | -$1.23 M(+70.5%) | -$4.00 M(+18.8%) |
| Mar 2000 | - | -$723.00 K(-41.9%) | -$3.37 M(+3.8%) |
| Dec 1999 | -$3.25 M(-1.5%) | -$1.25 M(+55.6%) | -$3.25 M(+62.3%) |
| Sep 1999 | - | -$800.00 K(+33.3%) | -$2.00 M(+66.7%) |
| Jun 1999 | - | -$600.00 K(0.0%) | -$1.20 M(+100.0%) |
| Mar 1999 | - | -$600.00 K | -$600.00 K |
| Dec 1998 | -$3.30 M(-9.4%) | - | - |
| Dec 1997 | -$3.64 M(+34.7%) | - | - |
| Dec 1996 | -$2.71 M(-511.2%) | - | - |
| Dec 1995 | $658.00 K | - | - |
FAQ
- What is Abeona Therapeutics annual free cash flow?
- What is the all time high annual FCF for Abeona Therapeutics?
- What is Abeona Therapeutics annual FCF year-on-year change?
- What is Abeona Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly FCF year-on-year change?
- What is Abeona Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Abeona Therapeutics?
- What is Abeona Therapeutics TTM FCF year-on-year change?
What is Abeona Therapeutics annual free cash flow?
The current annual FCF of ABEO is -$37.34 M
What is the all time high annual FCF for Abeona Therapeutics?
Abeona Therapeutics all-time high annual free cash flow is $658.00 K
What is Abeona Therapeutics annual FCF year-on-year change?
Over the past year, ABEO annual free cash flow has changed by +$6.27 M (+14.38%)
What is Abeona Therapeutics quarterly free cash flow?
The current quarterly FCF of ABEO is -$12.64 M
What is the all time high quarterly FCF for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly free cash flow is $2.23 M
What is Abeona Therapeutics quarterly FCF year-on-year change?
Over the past year, ABEO quarterly free cash flow has changed by $0.00 (0.00%)
What is Abeona Therapeutics TTM free cash flow?
The current TTM FCF of ABEO is -$50.57 M
What is the all time high TTM FCF for Abeona Therapeutics?
Abeona Therapeutics all-time high TTM free cash flow is $220.00 K
What is Abeona Therapeutics TTM FCF year-on-year change?
Over the past year, ABEO TTM free cash flow has changed by $0.00 (0.00%)